Business

Adaptimmune shares drop as Genentech terminates deal as soon as valued at $3 billion – San Francisco Enterprise Instances – The Enterprise Journals

Photo of Daily SF News Daily SF NewsApril 15, 2024
0 0 Less than a minute



Adaptimmune shares drop as Genentech terminates deal once valued at $3 billion – San Francisco Business Times  The Business Journals



Source link

Photo of Daily SF News Daily SF NewsApril 15, 2024
0 0 Less than a minute
Photo of Daily SF News

Daily SF News

Related Articles

Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Enterprise Occasions

Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Enterprise Occasions

May 10, 2024

San Francisco’s meals scene: China Stay expands for lunch, Boichik Bagels to open 3 new places

March 9, 2024

How a biotech startup, with contemporary money from key VCs, is utilizing AI to spin macrocycles – San Francisco Enterprise Instances – The Enterprise Journals

June 5, 2024

Day by day Digest: Money-guzzling Cruise will get refill; James Beard awards – The Enterprise Journals

June 12, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *

© Copyright 2025, All Rights Reserved  | 
Back to top button